© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Vickie and Jack Farber Institute for Neuroscience
Latest from Vickie and Jack Farber Institute for Neuroscience
The Clinical Potential of the SUDEP-3 Inventory
July 04, 2021
Article
Maromi Nei, MD, and Michael R. Sperling, MD, shared their insight on the novel inventory tool for predicting sudden unexpected death in epilepsy and their recently published work.
Novel SUDEP-3 Inventory Shows Potential to Predict SUDEP Risk
June 30, 2021
Article
The SUDEP-3 outperformed the prior SUDEP-7 variation on all measures, and simplifies the risk assessment with a 3-item weighted scoring while enhancing the clinical practicality.
Determining Migraine Treatment Eligibility: Stephanie J. Nahas, MD
May 27, 2021
Video
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the role of clinicians in determining migraine treatment eligibility.
Underutilization of Preventive Migraine Treatments: Stephanie J. Nahas, MD
May 21, 2021
Video
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the barriers to the use of preventive medicines.
NeuroVoices: Stephanie J. Nahas, MD, on Migraine Treatment Gaps and Optimization
May 19, 2021
Article
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed treatment optimization for patients with migraine and raising overall awareness for preventive treatments.
Optimizing Treatment in Acute Migraine: Stephanie J. Nahas, MD
May 07, 2021
Video
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the ways clinicians can tailor their treatment regimens better.